Agency Forms Undergoing Paperwork Reduction Act Review, 566-567 [E6-22579]
Download as PDF
<![CDATA[
566
Federal Register / Vol. 72, No. 3 / Friday, January 5, 2007 / Notices
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than January
18, 2007.
A. Federal Reserve Bank of
Minneapolis (Jacqueline G. King,
Community Affairs Officer) 90
Hennepin Avenue, Minneapolis,
Minnesota 55480-0291:
1. David A. Eickhoff, Adrian,
Minnesota, to acquire control of Adrian
Building Corporation and its subsidiary,
Adrian State Bank, both of Adrian,
Minnesota.
B. Federal Reserve Bank of Kansas
City (Donna J. Ward, Assistant Vice
President) 925 Grand Avenue, Kansas
City, Missouri 64198-0001:
1. David E. Pfrang, Goff, Kansas, and
Judy L. Georg, Sabetha, Kansas, acting in
concert to acquire control of Farmers
State Bankshares, Inc., and The Farmers
State Bank, both of Circleville, Kansas.
Board of Governors of the Federal Reserve
System, December 29, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E6–22590 Filed 1–4–07; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
sroberts on PROD1PC70 with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
VerDate Aug<31>2005
17:29 Jan 04, 2007
Jkt 211001
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 29,
2007.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30303:
1. CenterState Banks of Florida, Inc.,
Winter Haven, Florida, to merge with
Valrico Bancorp, Inc., and thereby
indirectly acquire Valrico State Bank,
both of Valrico, Florida.
B. Federal Reserve Bank of Kansas
City (Donna J. Ward, Assistant Vice
President) 925 Grand Avenue, Kansas
City, Missouri 64198-0001:
1. Frontier Management, LLC, and
Frontier Holdings, LLC, both of Omaha,
Nebraska; to acquire 100 percent of the
voting shares of Pender State Bank,
Pender, Nebraska.
Board of Governors of the Federal Reserve
System, December 29, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E6–22589 Filed 1–4–07; 8:45 am]
BILLING CODE 6210–01–S
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-07–425X]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
The National Centers for Autism and
Developmental Disabilities Research
and Epidemiology (CADDRE) Study—
New—National Center on Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Children’s Health Act of 2000
mandated CDC to establish autism
surveillance and research programs to
address the number, incidence,
correlates, and causes of autism and
related disabilities. Under the
provisions of this act, CDC funded 5
CADDRE centers: California Department
of Health and Human Services,
Colorado Department of Public Health
and Environment, Johns Hopkins
University, the University of
Pennsylvania, and the University of
North Carolina at Chapel Hill. CDC
National Center on Birth Defects and
Developmental Disabilities will
participate as the 6th site.
The purpose of this program is to
establish a multi-site, collaborative
epidemiological investigation of
possible causes of autism spectrum
disorders. Children with autism
spectrum disorders will be compared to
children with other developmental
problems, referred to as the
neurodevelopmentally impaired group
(NIC), as well as children who do not
have developmental problems, referred
to as the subcohort.
Data collection methods will consist
of the following: (1) Medical record
review of the child participant and
biological mother; (2) self-administered
E:\FR\FM\05JAN1.SGM
05JAN1
567
Federal Register / Vol. 72, No. 3 / Friday, January 5, 2007 / Notices
Questionnaires; (3) buccal cell
collection; (4) a telephone interview of
the biological mother and/or primary
caregiver; (5) a child development
evaluation (more comprehensive for
case participants than for the control
group participants); (6) parent-child
development interview (for case
participants only); (7) a physical exam
of the child; (8) biological sampling of
the child (blood and hair); and (9)
biological sampling of the biological
parents (blood only).
There are no costs to respondents
other than their time. The total
estimated annualized burden is 30,103
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Respondents
Contact by Mail ................................................................................................
Telephone Contact ..........................................................................................
Parent Questionnaires and biologic sample ....................................................
17,610
8,922
3,456
1
1
1
Caregiver Interview ..........................................................................................
Clinic Visit (Child Development Evaluation, physical exam, and biosamples):
• Case ......................................................................................................
3,282
1
810
1
• NIC ........................................................................................................
1,170
1
• Subcohort ..............................................................................................
1,134
1
TOTAL ...............................................................................................
........................
........................
Dated: December 26, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–22579 Filed 1–4–07; 8:45 am]
BILLING CODE 4163–18–P
Proposed Project
Morbidity Monitoring Project
(MMP)—New—National Center for HIV,
STD and TB Prevention (NCHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–07–05CG]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
The Morbidity Monitoring Project
(MMP) is a new project. The purpose of
MMP is to supplement the HIV/AIDS
surveillance programs in 26 selected
state and local health departments,
which collect information on persons
diagnosed with, living with, and dying
from HIV infection and AIDS and will
incorporate data elements from two data
collections: Supplement to HIV/AIDS
Surveillance (SHAS) project (0920–
0262) and the Adult/Adolescent
Spectrum of HIV Disease (ASD).
MMP will collect data on behaviors
and clinical outcomes from a probability
sample of HIV-infected adults receiving
care in the U.S. Collection of data from
interviews with HIV-infected patients
will provide information on patient
demographics, and the current levels of
behaviors that may facilitate HIV
transmission: sexual and drug use
behaviors; patients’ access to, use of and
barriers to HIV-related secondary
Average
burden per
response
(In hrs)
Total burden
hours
10/60
20/60
235/60
(3h 55m)
30/60
2,935
2,974
13,548
355/60
(5h 55m)
110/60
(1h 50m)
110/60
(1h 50m)
........................
4,793
1,641
2,145
2,079
30,103
prevention services; utilization of HIVrelated medical services; and adherence
to drug regimens. Collection of data
from patient medical records will
provide information on: demographics
and insurance status; the prevalence
and incidence of AIDS-defining
opportunistic illnesses and comorbidities related to HIV disease; the
receipt of prophylactic and
antiretroviral medications; and whether
patients are receiving screening and
treatment according to Public Health
Service guidelines. No other Federal
agency collects national populationbased behavioral and clinical
information from HIV-infected adults in
care.
The data will have significant
implications for policy, program
development, and resource allocation at
the state/local and national levels. Users
of MMP data include, but are not
limited to, Federal agencies, state and
local health departments, clinicians,
researchers, and HIV prevention and
care planning groups. There are no costs
to the respondents other than their time.
The total estimated annualized burden
hours are 6,101.
sroberts on PROD1PC70 with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Persons interviewed with standard interview ..............................................................................
Persons interviewed with short interview ....................................................................................
VerDate Aug<31>2005
17:29 Jan 04, 2007
Jkt 211001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\05JAN1.SGM
7,988
166
05JAN1
Number of
responses per
respondent
1
1
Average
burden per
response
(In hours)
45/60
20/60
]]>Agencies
[Federal Register Volume 72, Number 3 (Friday, January 5, 2007)]
[Notices]
[Pages 566-567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-22579]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-425X]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
The National Centers for Autism and Developmental Disabilities
Research and Epidemiology (CADDRE) Study--New--National Center on Birth
Defects and Developmental Disabilities (NCBDDD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Children's Health Act of 2000 mandated CDC to establish autism
surveillance and research programs to address the number, incidence,
correlates, and causes of autism and related disabilities. Under the
provisions of this act, CDC funded 5 CADDRE centers: California
Department of Health and Human Services, Colorado Department of Public
Health and Environment, Johns Hopkins University, the University of
Pennsylvania, and the University of North Carolina at Chapel Hill. CDC
National Center on Birth Defects and Developmental Disabilities will
participate as the 6th site.
The purpose of this program is to establish a multi-site,
collaborative epidemiological investigation of possible causes of
autism spectrum disorders. Children with autism spectrum disorders will
be compared to children with other developmental problems, referred to
as the neurodevelopmentally impaired group (NIC), as well as children
who do not have developmental problems, referred to as the subcohort.
Data collection methods will consist of the following: (1) Medical
record review of the child participant and biological mother; (2) self-
administered
[[Page 567]]
Questionnaires; (3) buccal cell collection; (4) a telephone interview
of the biological mother and/or primary caregiver; (5) a child
development evaluation (more comprehensive for case participants than
for the control group participants); (6) parent-child development
interview (for case participants only); (7) a physical exam of the
child; (8) biological sampling of the child (blood and hair); and (9)
biological sampling of the biological parents (blood only).
There are no costs to respondents other than their time. The total
estimated annualized burden is 30,103 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Respondents respondents responses per response (In hours
respondent hrs)
----------------------------------------------------------------------------------------------------------------
Contact by Mail................................. 17,610 1 10/60 2,935
Telephone Contact............................... 8,922 1 20/60 2,974
Parent Questionnaires and biologic sample....... 3,456 1 235/60 13,548
(3h 55m)
Caregiver Interview............................. 3,282 1 30/60 1,641
Clinic Visit (Child Development Evaluation,
physical exam, and biosamples):
Case............................... 810 1 355/60 4,793
(5h 55m)
NIC................................ 1,170 1 110/60 2,145
(1h 50m)
Subcohort.......................... 1,134 1 110/60 2,079
(1h 50m)
TOTAL................................... .............. .............. .............. 30,103
----------------------------------------------------------------------------------------------------------------
Dated: December 26, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-22579 Filed 1-4-07; 8:45 am]
BILLING CODE 4163-18-P
